Funded Grants April 2022

PIAgencyTitle
Jeffrey BednarskiAmerican Society of HematologyRole of DNA damage responses in B cell development
Patricia DicksonNIH/R01/University at Buffalo Enhancement of Newborn Screening Diagnostic Paradigms to Improve the Efficacy of Treatment for Krabbe Disease, Pompe Disease, and Mucopolysaccharidosis Type 1
Andrew GlatzHealthCore, Inc.COMPASS Co-Director
Cynthia OrtinauNIH/R01/Boston Children’s Hospital¬†Enhanced Imaging of the Fetal Brain Microstructure
Bryan SiskAmerican Society of Clinical OncologyCharacterizing the Perceived Risks, Benefits, Motivations, and Barriers to Accessing Electronic Health Information in Adolescent Oncology
Gregory StorchHRSA/St. Clair County DOHPerinatal Case Management
Funded Awards
Funded Grants June 2022

Name Agency Title Mohamed Abdelbaki Rally Foundation Natural Killer Cells in Children with Recurrent Malignant Brain Tumors David Bark NIH/R01 Impact of turbulence on blood in mechanical circulatory support Jeffrey Bednarski NIH/R21 MYSM1-dependent DNA damage responses in early B cell development Jeffrey Bednarski SLCH Foundation Pedal the Cause: Role of …

Funded Awards
Funded Grants May 2022

PI Agency Title Jeffrey Bednarski NIH/R21 MYSM1-dependent DNA damage responses in early B cell development Jeffrey Bednarski SLCH Foundation Pedal the Cause: Role of Maternal Obesity and Environmental Exposures in CNS tumor formation Nicole Brossier SLCH Foundation Pedal the Cause: Role of maternal obesity and environmental exposures in CNS tumor …

Funded Awards
Funded Grants March 2022

PI Agency Title Andrew Cluster University of California A Phase 1 Study of Modified Measles Virus (MV-NIS) for the Treatment of Children and Young Adults with Recurrent Medulloblastoma or Recurrent Atypical Teratoid Rhabdoid Tumors (ATRT) Jonathan Cooper NIH/R21 Defining and treating peripheral nervous system dysfunction in Cln1 disease Megan Cooper …